PrEParing for Lenacapavir Implementation in Your Clinic: Early Lessons Learned

PrEParing for Lenacapavir Implementation in Your Clinic: Early Lessons Learned

On June 18, 2025, the FDA approved Yeztugo, the brand name for subcutaneous lenacapavir, a prescription medication used for the pre-exposure prophylaxis of HIV. Subcutaneous lenacapavir is administered twice a year (every six months) to reduce the risk of sexually acquired HIV-1 infection in adults and adolescents at risk. With patients only needing lenacapavir twice a year for HIV prevention, the field has been optimistic about the potential for lenacapavir to reduce barriers and improve access to PrEP. Since we are still early in the rollout subcutaneous lenacapavir, many providers have questions about how to offer it to their patients—from workflow to billing to managing potential side effects and drug-drug interactions.

On this episode, Antonio Urbina, MD, Medical Director for CEI’s HIV Primary Care and Prevention Center of Excellence, speaks with Alex Danforth, PharmD. Alex Danforth is a clinical pharmacist in Rochester, NY. She practices at Trillium Health, a federally qualified health center, where she works with patients and providers to help manage medications and optimize care. Alex currently provides clinical leadership for HIV treatment and prevention programs.

Drs. Urbina and Danforth talk about the latest New York State Clinical Guidelines for PrEP, which were updated on October 16th. The new guidelines provide important updates, including subcutaneous lenacapavir. They discuss important considerations for initiating patients on lenacapavir as well as some early lessons learned from implementing lenacapavir in their Rochester- and New York City-based clinics. Related Content:

Jaksot(60)

Compassionate Care for LGBTQ+ Individuals Struggling with Substance Use Disorder

Compassionate Care for LGBTQ+ Individuals Struggling with Substance Use Disorder

Research suggests that LGBTQ adults have higher rates of substance use and mental health issues, compared to their heterosexual cisgender peers.  These health disparities are often related to minority...

12 Joulu 202428min

Reflections from the 2024 CDC STI Prevention Conference

Reflections from the 2024 CDC STI Prevention Conference

For the first time since 2018 and since the COVID-19 pandemic, the Centers for Disease Control and Prevention hosted their biennial STI Prevention Conference in-person in Atlanta, GA from September 16...

7 Marras 202422min

The Case for Chronic Pain Management among People Who Use Opioids

The Case for Chronic Pain Management among People Who Use Opioids

Are current guidelines failing chronic pain patients with a history of substance-use disorders? Find out why Dr. Wang and Dr. Kelly are calling for urgent policy changes and how updated guidelines can...

10 Loka 202446min

An Exciting New Twice-yearly Option for HIV PrEP

An Exciting New Twice-yearly Option for HIV PrEP

“This podcast discusses the recent presentation of data for lenacapavir, a potent capsid inhibitor for HIV that was 100% effective in preventing HIV infection in cis-gender woman at risk for HIV. If a...

10 Syys 202413min

When HIV Tests Perplex: Expert Insights on Ambiguous and Discordant Results

When HIV Tests Perplex: Expert Insights on Ambiguous and Discordant Results

Providers calling into our CEI hotline often ask me what to do when their patient's HIV test results are unclear. These ambiguous or discordant test results can be a source of anxiety and confusion fo...

8 Elo 202429min

It’s Complicated…but Necessary! Navigating Confidential Sexual Healthcare for Adolescents

It’s Complicated…but Necessary! Navigating Confidential Sexual Healthcare for Adolescents

“Nobody goes into adolescent medicine or into a field of medicine that serves adolescent patients because it’s simple and straightforward, right?” In May 2024, the New York State Department of Health ...

11 Heinä 202422min

Special Conversations with CEI: Best Practices for Hepatitis C and Pregnancy Screening: Advice from a Fellow Clinician

Special Conversations with CEI: Best Practices for Hepatitis C and Pregnancy Screening: Advice from a Fellow Clinician

Hepatitis C virus (HCV) is a pathogen spread by contact with blood from a person with HCV infection. Prevalence among the US obstetric population rose nearly 10-fold over the past 20 years and approxi...

13 Kesä 202434min

Special Conversations with CEI: Best Practices for Working with People Who Use Substances

Special Conversations with CEI: Best Practices for Working with People Who Use Substances

Hepatitis C virus (HCV) is a pathogen spread by contact with blood from a person with HCV infection. Prevalence among the US obstetric population rose nearly 10-fold over the past 20 years and approxi...

6 Kesä 202430min

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
voi-hyvin-meditaatiot-2
rss-narsisti
adhd-podi
psykopodiaa-podcast
rss-rahamania
rss-uskonto-on-tylsaa
rss-valo-minussa-2
rss-vapaudu-voimaasi
rss-duodecim-lehti
rss-niinku-asia-on
mielipaivakirja
rahapuhetta
aamukahvilla
ilona-rauhala
kesken
dear-ladies
rss-eron-alkemiaa
nakokulmia-rikollisuudesta-irrottautumiseen
rss-arkea-ja-aurinkoa-podcast-espanjasta